Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H22N2O3 |
Molecular Weight | 278.3468 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC(=O)NC1=C(C)C=CC=C1C(=O)OC
InChI
InChIKey=UDKICLZCJWQTLS-UHFFFAOYSA-N
InChI=1S/C15H22N2O3/c1-5-17(6-2)10-13(18)16-14-11(3)8-7-9-12(14)15(19)20-4/h7-9H,5-6,10H2,1-4H3,(H,16,18)
DescriptionSources: http://www.genome.jp/dbget-bin/www_bget?dr:D01878Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/9000257
Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01878
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/9000257
Tolycaine hydrochloride is an amide local anaesthetic included in some preparations to reduce the pain of injection. It can be used for dental injection.
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/9000257
Curator's Comment: shown to be CNS active in rats
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Small intestinal methyl leucine uptake Sources: http://www.ncbi.nlm.nih.gov/pubmed/10692555 |
|||
Target ID: Small intestinal methyl a-D-glucoside uptake Sources: http://www.ncbi.nlm.nih.gov/pubmed/10692555 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2489796 |
Palliative | Unknown Approved UseUnknown |
Sample Use Guides
Maximal dose - 250 mg for anorectal surgery
Route of Administration:
Intramuscular
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/10692555
5mM/l of Tolycaine inhibited 57% of control leucine uptake by rat jejunum
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000077768
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105549
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
DTXSID8057724
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
SUB11183MIG
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
m10970
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
3686-58-6
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
12R8659YM6
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
C105695
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
C75105
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
222-976-9
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
72137
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
1912
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY | |||
|
3619
Created by
admin on Fri Dec 15 15:49:30 GMT 2023 , Edited by admin on Fri Dec 15 15:49:30 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)